Cypris Medical

Cypris Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.2M

Overview

Cypris Medical is an innovator in the plastic surgery device space, addressing the unmet need for effective, minimally-invasive surgical tools. Its core technology, the Cypris ARC suturing device, utilizes proprietary ARC (Accurate Repeatable Capture) geometry and Negative Pressure Suturing (NPS) to enable precise tissue capture and suture delivery through small access points. The company is initially targeting facial and neck contouring procedures, with a pipeline exploring applications in breast reconstruction, body contouring, and general surgery. Led by a team with deep medical device and plastic surgery expertise, Cypris aims to commercialize technology designed by plastic surgeons for plastic surgeons.

Aesthetic & Reconstructive Plastic Surgery

Technology Platform

The Cypris ARC platform is a handheld surgical suturing system featuring proprietary ARC (Accurate Repeatable Capture) geometry for precise tissue purchase and Negative Pressure Suturing (NPS) for tissue capture via vacuum, enabling minimally-invasive precision suturing.

Funding History

1
Total raised:$1.2M
Seed$1.2M

Opportunities

The strong patient demand for minimally-invasive plastic surgery with shorter recovery times presents a major growth opportunity.
Success in facial aesthetics could enable rapid expansion into adjacent, large markets like breast and body contouring, as well as reconstructive surgery.

Risk Factors

The company faces significant commercialization and adoption risk as a single-product entity in a competitive market.
Its success is entirely dependent on plastic surgeons altering their techniques and accepting the ARC device, and any regulatory delays or product performance issues could be critical.

Competitive Landscape

Cypris ARC competes in the broad aesthetic surgery device market against large players like Allergan Aesthetics (AbbVie), Mentor (J&J), and numerous suture companies. Its direct competition includes other minimally-invasive lifting/suturing devices and techniques, but it claims uniqueness as the first device of its kind for precise, minimal-access suture delivery in plastic surgery.